ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
51 announcements
Global Health delivered strong results driven by high-occupancy and scale-up at Noida. Expansion remains aggressive with a new 500-bed Ghaziabad project.
Q2 FY27 revenue INR 14,690m (+33.6%), Operating EBITDA INR 3,701m (25.2% margin), PAT INR 2,191m (+38.3%). Volume-led growth; net cash INR 7,815m.
Global Health reported Q2 FY27 revenue of INR 14,690 million, up 33.6%, and PAT of INR 2,191 million, up 38.3%. Board approved a 500-bed Ghaziabad hospital.
Medanta plans a 500-bed Ghaziabad hospital over 3-4 years. Project cost is Rs 997 Crore, funded by internal accruals and debt.
Global Health Ltd reported revenue from operations of ₹1,469 Cr (+33.6% YoY) and net profit of ₹219.1 Cr (+38.3% YoY) for Q2 FY27.
Global Health granted 3,14,000 ESOPs to 45 employees at ₹635 under LTIP 2024. Its Senior VP & Head-HR also resigned, effective 23 December 2026.
Senior management personnel Dr Pankaj Dhamija, Gurugram Hospital Director, resigned with last working day 30 October 2026. He was relieved earlier than his contractual December 2026 date.
Global Health Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine Regulation 31 compliance statement with no transaction or business event.
Global Health allotted 2,750 equity shares to its ESOP Trust under the GHL LTIP 2024 employee scheme on 23 October 2026. Paid-up capital rose to ₹53,77,55,064 across 26,88,77,532 shares.
Global Health Limited will hold a board meeting on November 3, 2026, to consider and approve unaudited financial results for the second quarter and half year.
Global Health Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory reporting requirements.
Global Health Limited received ESG ratings from CRISIL for Fiscal Year 2026. The company was assigned a 'Crisil ESG 64' rating and a 'Crisil Core ESG 70'.
Global Health (Medanta) was allotted a 10,560 sq. metre land parcel in Ghaziabad for ₹165.82 crore. The site will house a new 350+ bed hospital.
Global Health Limited has been allotted a 10,560.36 sq. meter land parcel in Ghaziabad for Rs 165.82 Crore. The site will accommodate a 350+ bed hospital.
Global Health Limited has allotted equity shares under its ESOP/ESPS scheme. This action results in a minor increase in the company's total paid-up share capital.
Global Health Limited has allotted 3,000 equity shares under its employee stock option plan at a premium of Rs. 1,498 per share.
Global Health Limited held its 22nd Annual General Meeting on September 16, 2026. The meeting covered financial statement adoption and shareholder dividend declaration.
Global Health Limited has filed its Business Responsibility and Sustainability Report for the financial year 2025-26 as mandated by SEBI (LODR) regulations.
Global Health Limited has announced its 22nd Annual General Meeting to be held on September 16, 2026, to consider financial statements, dividends, and director re-appointment.
Global Health Limited has submitted its Annual Report for the financial year 2025-26, alongside the notice for its 22nd Annual General Meeting.
Global Health Ltd issued a notice for its 22nd Annual General Meeting, scheduled for September 16, 2026, via video conferencing to transact ordinary and special business.
Global Health (Medanta) delivered Q1 FY27 revenue growth of 26% YoY to INR 13,262 million, driven by robust patient volumes and scaling of the Noida facility.
Global Health (Medanta) delivered strong 26% revenue growth, fueled by higher patient volumes and a rapid turnaround in the new Noida facility.
Global Health (Medanta) reported 26.2% YoY revenue growth in Q1 FY27, driven by strong patient volumes and narrowing losses at the Noida facility.
Global Health reported Q1 FY2027 revenue of ₹1,326.2 Crore, up 26.2% YoY. The company added 72 beds during the quarter and plans a 650-bed Guwahati expansion.
Global Health Ltd will add 650 beds to its new Guwahati hospital project, requiring an investment of ₹970 Crore over the next 3-4 years.
Global Health Limited has appointed Mr. Pradeep Kumar Singh as the company's new Chief Digital Officer, effective July 30, 2026.
Global Health Ltd reported revenue from operations of ₹1,304 Cr (+26.5% YoY) and net profit of ₹157.3 Cr (-1.1% YoY) for Q1 FY27.
Global Health Ltd granted 20,000 ESOPs to one employee under the GHL LTIP 2024. The options have an exercise price of ₹1,147 each.
Global Health Ltd filed its quarterly shareholding pattern for the period ending June 30, 2026. The company also disclosed the allotment of 4,000 equity shares.